Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;1(3):e106.
doi: 10.1016/S2666-5247(20)30063-X. Epub 2020 Jul 3.

COVID-19-associated pulmonary aspergillosis: adding insult to injury

Affiliations
Comment

COVID-19-associated pulmonary aspergillosis: adding insult to injury

Giuseppe Bruno et al. Lancet Microbe. 2020 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • Diagnosing COVID-19-associated pulmonary aspergillosis.
    Verweij PE, Gangneux JP, Bassetti M, Brüggemann RJM, Cornely OA, Koehler P, Lass-Flörl C, van de Veerdonk FL, Chakrabarti A, Hoenigl M; European Confederation of Medical Mycology; International Society for Human and Animal Mycology; European Society for Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients. Verweij PE, et al. Lancet Microbe. 2020 Jun;1(2):e53-e55. doi: 10.1016/S2666-5247(20)30027-6. Epub 2020 May 10. Lancet Microbe. 2020. PMID: 32835328 Free PMC article. No abstract available.

References

    1. Verweij PE, Gangneux J-P, Bassetti M. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020 doi: 10.1016/S2666-5247(20)30027-6. published online May 8. - DOI - PMC - PubMed
    1. Koehler P, Cornely OA, Böttiger BW. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63:528–534. - PMC - PubMed
    1. Blaize M, Mayaux J, Nabet C. Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient. Emerg Infect Dis. 2020 doi: 10.3201/eid2607.201603. published online April 28. - DOI - PMC - PubMed
    1. Chen G, Wu D, Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–2629. - PMC - PubMed